University Hospital, Montpellier: Pulmonary Disease, Chronic Obstructive trials

The registry lists 13 Pulmonary Disease, Chronic Obstructive studies with University Hospital, Montpellier as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 4 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Benefits of Epithelial Repair in COPD by Induced Pluripotent Stem Cells (iPS)RecruitingNCT06755008Not applicable
• Chronic Airway Disease, Mucus Rheology and ExacerbationsRecruitingNCT04339270Phase 4
• Long-term Maintenance Benefits of a Pulmonary Rehabilitation Program Using a Mobile Digital Solution: a Prospective, Randomized, Controlled, Multicenter Study in a Population of COPD PatientsCompletedNCT04550741Not applicable
• Micro-environment Involvement in Muscle Alteration InducedCompletedNCT04448626
• Biological Determinants of Sputum Rheology in Chronic Airway DiseasesCompletedNCT04081740
• Determinants of the Vascular Response to Training in Chronic Obstructive Pulmonary Disease (COPD) PatientsTerminatedNCT03774238Not applicable
• Sevoflurane in Chronic Obstructive Pulmonary Disease ExacerbationTerminatedNCT03460015Not applicable
• Ciliation and Mucus Rheology Parameters Determined Via Air-liquid-interface Cell Cultures in Non-smoking, Smoking, COPD and Asthmatic PatientsTerminatedNCT03187860Not applicable
• Modeling Bronchial Epithelium Modifications Associated With COPD Using iPSCompletedNCT03181204
• Analysis of Inhaled Corticoid Prescriptions in General MedicineCompletedNCT03179826
• Determinants of Lower Limb Muscle Atrophy Induced During an Hospitalization for Exacerbation of COPDTerminatedNCT03153826Not applicable
• Muscle Training Induced Angiogenesis in COPDCompletedNCT02040363Not applicable
• Antioxidants and Pulmonary Rehabilitation in COPD PatientsCompletedNCT01942889Not applicable